AIM
ALXN

Assured Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Assured Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,522
Closed -$2.77M – 1019
2019
Q1 		$2.77M Sell
20,522
-17,424
-46% -$2.17M 0.03% 240
2018
Q4 		$3.69M Buy
37,946
+4,218
+13% +$499K 0.1% 247
2018
Q3 		$4.69M Buy
33,728
+14,766
+78% +$1.85M 0.09% 266
2018
Q2 		$2.35M Sell
18,962
-46,184
-71% -$5.4M 0.04% 379
2018
Q1 		$7.26M Buy
65,146
+7,630
+13% +$912K 0.17% 160
2017
Q4 		$6.88M Buy
57,516
+12,192
+27% +$1.48M 0.14% 164
2017
Q3 		$6.36M Buy
45,324
+24,723
+120% +$3.36M 0.13% 155
2017
Q2 		$2.51M Buy
20,601
+14,121
+218% +$1.64M 0.05% 226
2017
Q1 		$786K Buy
+6,480
New +$835K 0.02% 356
2016
Q4 		– Sell
-4,722
Closed -$579K – 720
2016
Q3 		$579K Buy
+4,722
New +$608K 0.01% 407
2015
Q2 		– Sell
-1,145
Closed -$198K – 750
2015
Q1 		$198K Buy
+1,145
New +$207K ﹤0.01% 431

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Assured Investment Management's ALXN Position: Q2 2019 in Review

Assured Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q2 2019, closing a stake of 20,522 shares — an estimated $2.77M sold.

Assured Investment Management first reported a position in ALXN in Q1 2015 and held it in 11 quarters. The position peaked at $7.26M in Q1 2018. 636 funds tracked by Wall St. Rank hold ALXN as of Q2 2019.

  • Assured Investment Management reported no remaining Alexion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 20,522 Alexion Pharmaceuticals shares in Q2 2019, an estimated $2.77M.
  • Assured Investment Management first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 11 quarters.
  • Assured Investment Management's Alexion Pharmaceuticals position peaked at $7.26M in Q1 2018.
  • 636 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.